Nobilis Therapeutics Inc
Biotechnology company · Portland, Oregon, United States
Nobilis Therapeutics Inc is a biotechnology company headquartered in Portland, Oregon, United States. Its earliest recorded incorporation is in 2015. It has received 1 US government small-business research award (SBIR/STTR) from health agencies, $319,992 in total, most recently in 2021. It has reported private securities offerings to the US SEC, most recently $500,000 sold in a notice filed in 2018.
Nobilis Therapeutics at a glance
What does Nobilis Therapeutics do?
US government research funding
1 SBIR/STTR small-business research award from US health agencies, $319,992 in total (2021). NIH funding came from the National Institute on Drug Abuse.
Private fundraising reported to the SEC
2 Form D notices; the most recent reported $500,000 sold (2018).
Frequently asked questions about Nobilis Therapeutics
Where is Nobilis Therapeutics headquartered?
Nobilis Therapeutics Inc is headquartered in Portland, Oregon, United States.
What does Nobilis Therapeutics do?
Nobilis Therapeutics Inc is a biotechnology company.
When was Nobilis Therapeutics founded?
The earliest incorporation on record for Nobilis Therapeutics Inc is in 2015, according to public company registers.
Similar companies
- Pacific Diabetes Technologies, Inc.Portland, Oregon, United States
- AMES Technology, Inc.Portland, Oregon, United States
- PDX Pharmaceuticals, Inc.Portland, Oregon, United States
- Aronora IncPortland, Oregon, United States
- Keliomics, Inc.Portland, Oregon, United States
- Boulder Care Provider Group, P.APortland, Oregon, United States
- CytoImage Inc.Portland, Oregon, United States
- Sedia Biosciences CorpPortland, Oregon, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-25. Data licences